Clinical Trial Update: Nimotuzumab Combined With Chemoradiotherapy in the Treatment of Unresectable Locally Advanced or Oligometastatic Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating nimotuzumab in combination with chemoradiotherapy for unresectable locally advanced or oligometastatic pancreatic cancer; enro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Nimotuzumab (nimotuzumab)

Snippet

Sponsor: Peking University First Hospital | Conditions: Pancreatic Cancer Non-resectable | Phase 2 | Status: ENROLLING_BY_INVITATION